Octave Bioscience
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1440 Obrien Dr Ste B, Menlo Park, Califo...Phone Number
(650) 233-2750Website
www.octavebio.comRevenue
$22.8 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About Octave Bioscience
Octave Bioscience, Inc specializes in the development of innovative diagnostic tests, particularly the MSDA Test, which is the first multi-analyte blood test designed to monitor multiple sclerosis (MS) disease activity. This test provides detailed, personalized reporting that empowers both patients and healthcare providers to make informed care decisions. The company aims to enhance clinical insights for neurodegenerative diseases, thereby transforming patient care. Their services are available nationwide through Quest Diagnostics, targeting both healthcare providers and patients affected by MS.Explore more
Octave Bioscience Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Octave Bioscience your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Octave Bioscience has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Octave Bioscience launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Octave Bioscience
Check out if Octave Bioscience is spiking on competitors!
Earning: See what the market has to say on Octave Bioscience recently announced quarterly report
Click to see if Octave Bioscience had a recent Job posting/layoffs
Octave Bioscience, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Octave Bioscience has new funding data
Recommended Actions
Find VP level buyers at Octave Bioscience
Find 2 more new buyers
Compare Similar Companies to Octave Bioscience
Compare insights from companies similar to Octave Bioscience, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Octave Bioscience is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Octave Bioscience is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Octave Bioscience.
Octave Bioscience financials insights
Gather financial insights about Octave Bioscience, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Angel/Seed
$2.5M
2018
Series A
$14M
2023
Series B
$62M
2025
Debt
$15.5M
Series C
$35M
Octave Bioscience Tech Stack
A closer look at the technologies used by Octave Bioscience
Most Recent Scoops
Person-Based
Product Development, Medical Research
Person-Based
Funding
Funding
Funding
Funding
Person-Based
Octave Bioscience News & Media
Octave Bioscience Expands Medical Leadership to Accelerate Precision Care in Neurodegenerative Disease
MENLO PARK, Calif.--(BUSINESS WIRE)-- #Biomarkers--Octave Bioscience, Inc., a leading precision care company that is delivering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced the appointments of Jennifer Graves, MD, PhD, MAS as Senior Medical Director and Darin Okuda, M.D., M.Sc., F.A.A.N., F.A.N.A., as Senior Medical Advisor, and the promotion of Terrie Livingston, PharmD, to Vice President, Medical Affairs. The extensive experience of this wOctave MSDA Test Gains NY State Certification, Expanding Access Nationwide
MENLO PARK, Calif.--(BUSINESS WIRE)-- #Biomarkers--Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, announced today the Octave Multiple Sclerosis Disease Activity (MSDA) Test has received certification from the New York State Clinical Laboratory Evaluation Program (CLEP), which maintains the highest quality standards found in the U.S. The Octave MSDA Test is the first and only multi-Octave® Bioscience Continues Commercial Momentum with Addition of Accomplished CFO Marcel Konrad
MENLO PARK, Calif.--(BUSINESS WIRE)--Octave® Bioscience, a leading precision care company transforming the management of multiple sclerosis (MS) and other neurodegenerative diseases, today announced the appointment of Marcel Konrad as Chief Financial Officer. Marcel brings a distinguished track record in scaling high-growth therapeutic and diagnostic companies to Octave as the company enters a pivotal phase of commercial expansion. The addition of Marcel follows several new appointments of provOctave® Bioscience, Inc. Announces Publication in Nature Communications
MENLO PARK, Calif.--(BUSINESS WIRE)--Octave® Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases, today announced the publication of a landmark manuscript in the prestigious journal, Nature Communications. The manuscript reports on several studies demonstrating Octave's innovative, multi-protein approach to characterize disease activity in MS patients through a comprehensive biomarker panel tha
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Octave Bioscience
Sign Up For FreeTo access detailed company insights
Octave Bioscience, Inc specializes in the development of innovative diagnostic tests, particularly the MSDA Test, which is the first multi-analyte blood test designed to monitor multiple sclerosis (MS) disease activity. This test provides detailed, personalized reporting that empowers both patients and healthcare providers to make informed care dec... Read More
